Larotrectinib and Somatropin (rDNA origin - Nonrefrigerated) (SBS)
Determining the interaction of Larotrectinib and Somatropin (rDNA origin - Nonrefrigerated) (SBS) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Somatropin may reduce the blood levels of larotrectinib, which may make the medication less effective in some cases. Contact your doctor if your symptoms worsen or your condition changes. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with inducers of CYP450 3A4 and/or P-glycoprotein (P-gp) may decrease the plasma concentrations of larotrectinib, which is primarily metabolized by the isoenzyme as well as the efflux transporter. When a single 100 mg dose of larotrectinib was coadministered with rifampin, a potent CYP450 3A4 and P-gp inducer, larotrectinib peak plasma concentration (Cmax) and systemic exposure (AUC) decreased by 71% and 81%, respectively, compared to administration of larotrectinib alone. Reduced efficacy of larotrectinib may occur. The interaction has not been studied with other, less potent inducers.
MANAGEMENT: The potential for diminished pharmacologic effects of larotrectinib should be considered during coadministration with CYP450 3A4 and P-gp inducers. Some authorities advise that concomitant use of larotrectinib with moderate CYP450 3A4 and/or P-gp inducers should be avoided (UK). Alternative treatments may be required if an interaction is suspected.
- "Product Information. Vitrakvi (larotrectinib)." Bayer Pharmaceutical Inc, West Haven, CT.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: n.a.
Generic Name: somatropin
Brand name: Genotropin, Humatrope, Norditropin FlexPro Pen, Nutropin AQ NuSpin 10, Nutropin AQ Pen 10 Cartridge, Omnitrope, Saizen, Serostim, Zomacton, Zorbtive, Nutropin, Norditropin, Nutropin AQ, Nutropin Depot, Norditropin Cartridge, Genotropin Miniquick, Tev-Tropin, Norditropin Nordiflex Pen, Saizen Click-Easy, Omnitrope Pen 5 Cartridge, HumatroPen, Omnitrope Pen 10 Cartridge, Nutropin AQ Pen 20 Cartridge, Nutropin AQ NuSpin 5, Nutropin AQ NuSpin 20, Saizen Kit
Synonyms: Somatropin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib-Somatropin (rDNA origin)
- Larotrectinib-Somatropin for Weight Gain
- Larotrectinib-Somatropin, e-coli derived Subcutaneous, Injection
- Larotrectinib-Somatropin, mammalian derived Subcutaneous, Injection
- Larotrectinib-Somatuline Depot
- Larotrectinib-Somavert
- Somatropin (rDNA origin - Nonrefrigerated) (SBS)-Larotrectinib Capsules
- Somatropin (rDNA origin - Nonrefrigerated) (SBS)-Larotrectinib Oral Solution
- Somatropin (rDNA origin - Nonrefrigerated) (SBS)-Larotrectinib Sulfate
- Somatropin (rDNA origin - Nonrefrigerated) (SBS)-Lartruvo
- Somatropin (rDNA origin - Nonrefrigerated) (SBS)-Larynex
- Somatropin (rDNA origin - Nonrefrigerated) (SBS)-Laryng-O-Jet